JP2022545416A5 - - Google Patents

Info

Publication number
JP2022545416A5
JP2022545416A5 JP2022510804A JP2022510804A JP2022545416A5 JP 2022545416 A5 JP2022545416 A5 JP 2022545416A5 JP 2022510804 A JP2022510804 A JP 2022510804A JP 2022510804 A JP2022510804 A JP 2022510804A JP 2022545416 A5 JP2022545416 A5 JP 2022545416A5
Authority
JP
Japan
Prior art keywords
cells
tcrαβ
population
precursor
icos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022510804A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022545416A (ja
Filing date
Publication date
Priority claimed from GBGB1911958.5A external-priority patent/GB201911958D0/en
Application filed filed Critical
Publication of JP2022545416A publication Critical patent/JP2022545416A/ja
Publication of JP2022545416A5 publication Critical patent/JP2022545416A5/ja
Pending legal-status Critical Current

Links

JP2022510804A 2019-08-20 2020-08-20 Ｔ細胞の生産方法 Pending JP2022545416A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1911958.5A GB201911958D0 (en) 2019-08-20 2019-08-20 Methods of t cell production
GB1911958.5 2019-08-20
PCT/EP2020/073332 WO2021032836A1 (en) 2019-08-20 2020-08-20 Methods of t cell production

Publications (2)

Publication Number Publication Date
JP2022545416A JP2022545416A (ja) 2022-10-27
JP2022545416A5 true JP2022545416A5 (enExample) 2023-08-18

Family

ID=68099410

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022510804A Pending JP2022545416A (ja) 2019-08-20 2020-08-20 Ｔ細胞の生産方法

Country Status (9)

Country Link
US (1) US20220267729A1 (enExample)
EP (1) EP4017966A1 (enExample)
JP (1) JP2022545416A (enExample)
KR (1) KR20220047376A (enExample)
CN (1) CN114364790A (enExample)
AU (1) AU2020332059A1 (enExample)
CA (1) CA3150425A1 (enExample)
GB (1) GB201911958D0 (enExample)
WO (1) WO2021032836A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022241558A1 (en) * 2021-05-18 2022-11-24 The University Of British Columbia A method for producing blood progenitor and progenitor t cells, resulting cells and methods and uses thereof
GB202205572D0 (en) 2022-04-14 2022-06-01 Adaptimmune Ltd Engineered T cells
GB202208545D0 (en) 2022-06-10 2022-07-27 Adaptimmune Ltd Production of immune cells
CN120303393A (zh) * 2022-10-05 2025-07-11 迦鲁达细胞疗法公司 多能干细胞来源的t细胞群体及其祖细胞
GB202318950D0 (en) 2023-12-12 2024-01-24 Adaptimmune Ltd Production of immune cells

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7575925B2 (en) * 2002-12-10 2009-08-18 Sunnybrook Health Sciences Centre Cell preparations comprising cells of the T cell lineage and methods of making and using them
EP2531216B1 (en) * 2010-02-04 2019-03-27 The Trustees Of The University Of Pennsylvania Icos critically regulates the expansion and function of inflammatory human th17 cells
MX2018005274A (es) * 2015-10-30 2019-09-19 The Regents Of The Universtiy Of California Metodos para la generacion de celulas-t a partir de celulas madre y metodos inmunoterapeuticos que utilizan las celulas-t.
GB201616238D0 (en) * 2016-09-23 2016-11-09 Adaptimmune Ltd Modified T cells
US12006512B2 (en) * 2017-01-20 2024-06-11 Kyoto University Method for producing CD8alpha+beta+ cytotoxic t cells
AU2018235130B2 (en) * 2017-03-15 2023-12-07 Oxford Biomedica (Uk) Limited Method
EP3601573A4 (en) * 2017-03-29 2020-12-23 Sunnybrook Research Institute GENETICALLY MODIFIED T-LYMPHOCYTES MODULATING MOLECULES AND ASSOCIATED PROCEDURES FOR USE
WO2019018603A2 (en) * 2017-07-19 2019-01-24 Fate Therapeutics, Inc. COMPOSITIONS AND METHODS FOR MODULATION OF IMMUNE CELLS IN ADOPTIVE IMMUNOTHERAPIES
GB202102297D0 (en) * 2021-02-18 2021-04-07 Adaptimmune Ltd Methods of Producing Haemogenic Endothelial Cells from Pluripotent Stem Cells

Similar Documents

Publication Publication Date Title
JP7560502B2 (ja) 多能性幹細胞からｈｌａホモ接合免疫細胞への指向分化方法
US12129486B2 (en) Methods for directed differentiation of pluripotent stem cells to immune cells
JP2019083819A (ja) ヒト胚性幹細胞由来血管芽細胞からナチュラルキラー細胞および樹状細胞を生成する方法
JP2022545782A5 (enExample)
JP7522800B2 (ja) 造血移植片の改善方法
JP2022545415A5 (enExample)
JP2020506713A (ja) 多能性幹細胞から模倣自然免疫細胞を生成する方法及びキット
US20230210904A1 (en) Pharmaceutical containing helper t cells induced from pluripotent stem cells
JP2022545078A5 (enExample)
US20150087065A1 (en) Method for generation of conditionally immortalized hematopoietic progenitor cell lines with multiple lineage potential
US20240240149A1 (en) A method for producing blood progenitor and progenitor t cells, resulting cells and methods and uses thereof
CA3024273A1 (en) Selection of human hematopoetic stem cells using epcr
CN115698270A (zh) 一种通过iPS细胞生产再生T细胞的方法
Kawai et al. Feeder-free generation of CD4 single-positive helper T cells from human iPSCs via stage-specific modulation of Notch and TCR Signaling
AU2019376495B2 (en) Method for producing erythroid cells
CN117480249A (zh) 包含未重排的t细胞受体(tcr)基因座的干细胞及其使用方法
Botó ZBTB46 and RUNX3 Regulated Blood Cell Differentiation from Pluripotent Embryonic Stem Cells
WO2026011501A1 (zh) 一种靶向cd19的car-nk细胞及其制备方法和应用
CN117866894A (zh) 一种成纤维细胞转分化为巨噬细胞的方法
JP2025534356A (ja) 細胞療法のためのｃｄ７１＋赤血球前駆細胞の拡張可能な拡大培養
JPWO2021085450A1 (ja) マウスｍａｉｔ様細胞及びｍａｉｔ細胞豊富なマウス
Crooks Common lymphoid progenitors